Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 2,41,365 1,91,427 1,91,088 1,96,184 2,17,859 1,82,902 - -
Change - -20.69% -0.18% 2.67% 11.05% -16.05% - -
Enterprise Value (EV) 1 2,49,166 1,98,318 1,98,871 2,02,693 2,22,266 2,07,067 2,04,318 2,00,517
Change - -20.41% 0.28% 1.92% 9.66% -6.84% -1.33% -1.86%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 30.3x 23.4x 21x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 3.8x 3.64x 3.43x
PEG - -36.9x -2x 0x -0.7x -4.95x 0.8x 1.8x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.64x 3.35x 3.13x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 4.12x 3.74x 3.43x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 16x 14.1x 12.7x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 17.7x 15.7x 14x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 26.1x 21.8x 19.6x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 3.83% 4.58% 5.09%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.577 2.739 2.854
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.44% 2.59% 2.7%
EPS 2 3.94 3.91 3.26 7.64 3.72 3.492 4.522 5.038
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 73.8% 60.6% 56.7%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,304 54,649 58,413
EBITDA 1 12,815 12,485 10,188 10,635 11,735 12,951 14,445 15,797
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,718 13,019 14,321
Net income 1 7,071 6,933 5,723 13,402 6,524 6,255 7,923 8,786
Net Debt 1 7,801 6,891 7,783 6,509 4,407 24,166 21,416 17,615
Reference price 2 140.74 109.79 110.07 113.11 125.29 105.70 105.70 105.70
Nbr of stocks (in thousands) 17,14,968 17,43,574 17,36,059 17,34,455 17,38,834 17,30,383 - -
Announcement Date 26/01/22 25/01/23 24/01/24 22/01/25 22/01/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
19.35x3.38x11.9x3.48% 11TCr
17.32x0.19x12.22x0.76% 6.06TCr
30.21x7.51x18.82x1.35% 5.18TCr
36.06x3.22x10.97x2.37% 4.56TCr
37.66x1.37x12.1x0.21% 3.32TCr
33.77x5.98x18.8x-.--% 3.15TCr
39.76x6.96x24.98x0.26% 2.4TCr
24.32x3.69x12.93x1.14% 2.23TCr
20.37x2.82x10.88x1.55% 2.15TCr
Average 28.76x 3.90x 14.85x 1.24% 4.44TCr
Weighted average by Cap. 26.57x 3.65x 14.09x 1.69%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ABT Stock
  5. Valuation Abbott Laboratories